Merck to acquire Prometheus for $10.8 billion – European Pharmaceutical Review

Merck to acquire Prometheus for $10.8 billion  European Pharmaceutical Review
Source: Merck to acquire Prometheus for .8 billion – European Pharmaceutical Review